BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10925618)

  • 21. [Cerebrovascular disorders and administration of oral contraceptives containing gestodene--causal relation or coincidence?].
    König HJ; Anagnostopoulos-Schleep J; Mewe R
    Med Klin (Munich); 1991 Jul; 86(7):333-7, 382. PubMed ID: 1921893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Does multiple sclerosis facilitate migraine].
    Kropp P; Müller B; Barchmann D; Angeli A; Straube A;
    Fortschr Neurol Psychiatr; 2011 Aug; 79(8):467-9. PubMed ID: 21809259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine and use of combined hormonal contraceptives: a clinical review.
    MacGregor EA
    J Fam Plann Reprod Health Care; 2007 Jul; 33(3):159-69. PubMed ID: 17609074
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review.
    Curtis KM; Mohllajee AP; Peterson HB
    Contraception; 2006 Feb; 73(2):189-94. PubMed ID: 16413849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FPIN's clinical inquiries. Cardiovascular risk of combined oral contraceptive use.
    Fehr AD; Mounsey A; Yates JE; Flake D
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316994
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined oral contraceptives in women with menstrual migraine without aura.
    De Leo V; Scolaro V; Musacchio MC; Di Sabatino A; Morgante G; Cianci A
    Fertil Steril; 2011 Oct; 96(4):917-20. PubMed ID: 21843889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Novynette--trends in contraception at the beginning of the new millennium].
    Ivanov S; Sigridov I
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273
    [No Abstract]   [Full Text] [Related]  

  • 29. [Escapelle - a method of choice for emergency contraception ].
    Tanchev L
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
    [No Abstract]   [Full Text] [Related]  

  • 30. [Back up contraception].
    Dacheva T
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
    [No Abstract]   [Full Text] [Related]  

  • 31. [A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive].
    Ruíz Moreno JA; Rubio Lotvin B; Bolio Arista R; de Larios NM
    Ginecol Obstet Mex; 1977 Feb; 41(244):179-84. PubMed ID: 321297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migraine headaches may increase stroke risk, study finds. People with visual symptoms of migraines are particularly vulnerable; women are especially at risk.
    Duke Med Health News; 2010 Mar; 16(3):7. PubMed ID: 20461883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection].
    Samuelsson E; Hultdin J; Groth K; Hedenmalm K
    Lakartidningen; 2007 Jan 10-16; 104(1-2):32-4. PubMed ID: 17323737
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
    Milchev N; Terzhumanov R; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
    Reid RL; Fortier MP; Smith L; Mirkin S; Grubb GS; Constantine GD
    Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Terakawa N; Taketani Y; Hoshiai H
    Fertil Steril; 2011 May; 95(6):1928-31. PubMed ID: 21420678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
    Lippman JS; Shangold GA
    Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined oral contraceptives with extremely low doses of estrogen (15 micrograms in a single tablet)].
    Cepický P; Dvorák K; Holub Z; Uzel R
    Ceska Gynekol; 2001 Jul; 66(4):297-9. PubMed ID: 11569429
    [No Abstract]   [Full Text] [Related]  

  • 39. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age.
    Donaghy M; Chang CL; Poulter N;
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):747-50. PubMed ID: 12438482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of low-dose oral contraceptive regulon-Gedeon Richter on some hemostatic variables].
    Uchikova E; Ledzhev I; Milchev N; Tsvetkova T
    Akush Ginekol (Sofiia); 2004; 43(2):58-62. PubMed ID: 15185533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.